Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • PI3K
    (2)
  • Akt
    (1)
  • Apoptosis
    (1)
  • BTK
    (1)
  • COX
    (1)
  • PPAR
    (1)
  • S6 Kinase
    (1)
  • mTOR
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (5)
  • Immune System
    (4)
  • Inflammation
    (4)
  • Cardiovascular System
    (1)
Filter
Search Result
Results for "

sc236

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    5
    TargetMol | All_Pathways
  • SC-236
    Sc 236
    T8505170569-86-5
    SC-236 (Sc 236) is an orally active and selective inhibitor of COX-2 (IC50 of 0.005 μM and 17.8 μM for COX-2 and COX-1, respectively).
    • $41
    In Stock
    Size
    QTY
  • MSC2360844
    T121151305267-37-1In house
    MSC2360844 is a potent, orally active and selective inhibitor of PI3Kδ(IC50 of 145 nM).
    • $48
    In Stock
    Size
    QTY
  • MSC2360844 hemifumarate
    T390941621688-31-0
    MSC2360844 hemifumarate is a highly potent and orally active compound that acts as a selective inhibitor of PI3Kδ, with an IC50 value of 145 nM. This compound exhibits exceptional selectivity against a comprehensive panel of 278 additional kinases.
      Inquiry
    • M2698
      MSC2363318A
      T119281379545-95-5
      M2698 (MSC2363318A) is an inhibitor of p70S6K, Akt1 and Akt3 with IC50s of 1 nM. M2698 shows anti-cancer activity.
      • $43
      In Stock
      Size
      QTY
    • evobrutinib
      MSC2364447C, M2951
      T43871415823-73-2
      Evobrutinib(M2951) , also known as M-2951 and MSC-2364447C, is a highly selective inhibitor of the Bruton's tyrosine kinase (BTK), which is important in the development and functioning of various immune cells including B -lymphocytes and macrophages. PreClinical research suggests it may be therapeutically useful in certain autoimmune diseases.
      • $35
      In Stock
      Size
      QTY